# Tirzepatide: UK patient leaflet, explained

Source: patient information leaflet for Mounjaro 7.5 mg Kwikpen Solution For Injection In Pre-Filled Pen (licence PLPI457631014), approved by the MHRA. Leaflet dated 2026-07-10. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/c6d0c7bea4df62316908c39d37e2bd275f954129

Canonical page: https://pestle.health/uk/tirzepatide

## What is tirzepatide for?
Mounjaro is a once-weekly injection used in adults with type 2 diabetes to lower blood sugar, on its own if metformin cannot be taken or with other diabetes medicines. It is also used with a reduced-calorie diet and more physical activity for weight loss and weight maintenance in adults with obesity, or with overweight plus weight-related health problems.

## Key facts
- Inject once a week under the skin of your stomach area, upper leg or upper arm, on the same day each week if you can.
- Do not change your dose unless your doctor tells you to. The starting dose is 2.5 mg weekly for four weeks, then your doctor will increase it.
- Stop using it and get urgent medical help if you have severe, persistent stomach pain, which could be acute pancreatitis, or signs of a severe allergic reaction.
- Low blood sugar can occur if you use it with a sulphonylurea or insulin, so test your blood glucose as instructed.
- It should not be used in pregnancy and should not be given to anyone under 18 years of age.

## Who should not take tirzepatide?
- If you are allergic to tirzepatide or any of the other ingredients of this medicine

## Check with a doctor or pharmacist first if
- Severe problems with food digestion or food staying in your stomach longer than normal (including severe gastroparesis)
- You have ever had pancreatitis (inflammation of the pancreas)
- Eye problems (diabetic retinopathy or macular oedema)
- You use a sulphonylurea or insulin for your diabetes, as low blood sugar (hypoglycaemia) can occur and your doctor may need to change your dose
- Loss of fluids/dehydration (for example from vomiting, nausea or diarrhoea) when starting treatment, which may lead to a decrease in kidney function. Drink plenty of fluids
- You are due to have surgery under anaesthesia
- You have a liver or kidney disease (the medicine contains benzyl alcohol, which can build up in the body)
- Not for children and adolescents under 18 years of age

## Side effects that need urgent help
- Inflamed pancreas (acute pancreatitis) causing severe pain in the stomach and back that does not go away (uncommon)
- Severe, persistent pain in the stomach area (abdomen), with or without nausea and vomiting, which could be a sign of acute pancreatitis: stop using the medicine and seek urgent medical help (uncommon)
- Severe allergic reactions (e.g. anaphylactic reaction, angioedema), with symptoms such as breathing problems, rapid swelling of the lips, tongue and/or throat with difficulty swallowing, and a fast heartbeat (rare)

## How common are the side effects?
### Very common (More than 1 in 10 people)
- Low blood sugar (hypoglycaemia) when tirzepatide is used for type 2 diabetes with medicines that contain a sulphonylurea and/or insulin
- Feeling sick (nausea)
- Diarrhoea
- Being sick (vomiting)
- Stomach (abdominal) pain
- Constipation

### Common (Up to 1 in 10 people)
- Low blood sugar (hypoglycaemia) when tirzepatide is used for type 2 diabetes with both metformin and a sodium-glucose co-transporter 2 inhibitor
- Allergic reaction (hypersensitivity) (e.g. rash, itching, and eczema)
- Dizziness observed in patients treated for weight management
- Low blood pressure observed in patients treated for weight management
- Feeling less hungry (decreased appetite) observed in patients treated for type 2 diabetes
- Indigestion (dyspepsia)
- Bloating of the stomach
- Burping (eructation)
- Gas (flatulence)
- Reflux or heartburn (gastroesophageal reflux disease, GORD)
- Hair loss observed in patients treated for weight management
- Feeling tired (fatigue)
- Injection site reactions (e.g. itching or redness)
- Fast pulse
- Increased levels of pancreatic enzymes (such as lipase and amylase) in blood
- Increased calcitonin levels in blood
- Gallstones
- Vomiting (when treated for type 2 diabetes)
- Stomach (abdominal) pain (when treated for type 2 diabetes)
- Constipation (when treated for type 2 diabetes)

### Uncommon (Up to 1 in 100 people)
- Inflamed pancreas (acute pancreatitis)
- Low blood sugar (hypoglycaemia) when tirzepatide is used with metformin for type 2 diabetes
- Weight loss observed in patients treated for type 2 diabetes
- Injection site pain
- Cholecystitis (infection of the gallbladder) observed in patients treated for weight management
- Changed sense of taste
- Change in skin sensation
- A delay in the emptying of the stomach
- Fast pulse (when used for weight management)
- Increased levels of amylase (in weight management)
- Increased calcitonin levels in blood (when used for type 2 diabetes)
- Gallstones (when used for type 2 diabetes)

### Rare (Up to 1 in 1,000 people)
- Severe allergic reactions (e.g. anaphylactic reaction, angioedema)

## Other medicines the leaflet mentions
- Any other medicines you are using, have recently used or might use
- Sulphonylureas (another diabetes medicine), as your doctor may need to change the dose
- Insulin, as your doctor may need to change the dose
- Oral contraceptives (if you are a woman with obesity or overweight, consider a barrier method or a non-oral contraceptive for 4 weeks after starting and after each dose increase)

## Pregnancy and breastfeeding
Do not use during pregnancy as the effects on an unborn child are not known. Ask your doctor for advice if you are pregnant, think you may be or plan a baby, and use contraception while using it. It is unknown whether tirzepatide passes into breast milk, so talk to your doctor before using it if you are breast-feeding or plan to breast-feed.

## How to take it
- Inject once a week under the skin (subcutaneously) of your stomach area, upper leg or upper arm, choosing a different injection site each time. You may need help to inject in your upper arm.
- The starting dose is 2.5 mg once a week for four weeks, then 5 mg once a week. Your doctor may increase it in 2.5 mg steps up to 15 mg, staying on each dose for at least 4 weeks. Do not change your dose unless your doctor tells you to.
- Use it at any time of day, with or without meals, on the same day each week if you can. You can change the injection day if it has been at least 3 days since your last injection.
- If you miss a dose by 4 days or less, inject it as soon as you remember. If more than 4 days, skip it and inject on your usual day. Never use a double dose.
- Read the Instructions for Use before using the pen. Each pen contains 4 doses and should be discarded after the 4th dose or 30 days after first use.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
